What is Haleos Labs Ltd (HALEOSLABS) share price return in the past 10 years?

Data is not available for this company

What is the share price of Haleos Labs Ltd (HALEOSLABS)?

Company share prices are keep on changing according to the market conditions. The current trading price of Haleos Labs Ltd (HALEOSLABS) on 04-Jun-2026 16:59:59 at 16:59 is 1400.00.

What is the P/E ratio of Haleos Labs?

The latest standalone P/E ratio of Haleos Labs as of 04-Jun-2026 is 23.81.

What is the P/B ratio of Haleos Labs Ltd (HALEOSLABS)?

The latest standalone P/B ratio of Haleos Labs Ltd (HALEOSLABS) as of 04-Jun-2026 is 1.97.

What is the 52-week high and low of Haleos Labs Ltd (HALEOSLABS)?

The 52-week high of Haleos Labs Ltd (HALEOSLABS) is Rs. 1778.35 and the 52-week low is Rs. 1050.05.

Haleos Labs Ltd (HALEOSLABS) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Haleos Labs Ltd (HALEOSLABS)
Brand: Haleos Labs

Haleos Labs Ltd (HALEOSLABS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540679 NSE: HALEOSLABS Pharmaceuticals & Drugs | Small Cap | Haleos Labs Share Price

Haleos Labs Ltd (HALEOSLABS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540679 NSE: HALEOSLABS Pharmaceuticals & Drugs | Small Cap | Haleos Labs Share Price

Key Metrics

Valuation Multiples

Market Cap

₹423 Cr.

Current Price

₹1,400

52-Week Low / High

₹1,050 / 1,778

TTM EPS

₹58.8

TTM Sales

₹301 Cr.

Book Value per Share

₹709.8

P/E Ratio

23.81

Higher than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

1.97

Higher than its 5-year historical median

Price to Sales (P/S)

1.41

Higher than its 5-year historical median

EV/EBITDA

12.29

Higher than its 5-year historical median

Dividend Yield

0.14%

Profitability Efficiency

Return on Equity (ROE)

11.45%

Outperforms industry median

Return on Capital Employed (ROCE)

14.03%

Outperforms industry median

Return on Assets (ROA)

5.95%

Operating Profit Margin

13.3%

Net Profit Margin

6.41%

Gross Profit Margin

10.9%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

11.12%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

28.23%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

63.5%

Asset Quality

Promoter Holding

72.11%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹212 Cr.

Equity

₹3 Cr.

Face Value

₹10

All Time Low / High

₹134.85 / 1778.35

Haleos Labs stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is Haleos Labs Ltd a good quality company?

Haleos Labs Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Haleos Labs Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Haleos Labs Ltd vs industry peers?

Haleos Labs Ltd revenue CAGR is 5.35%, compared to the industry median CAGR of 5.35%, indicating stable growth and maintaining its market share.

Q.1 Promoter shareholding and pledge status of Haleos Labs Ltd?

Promoters hold 72.11% of the Haleos Labs Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Haleos Labs Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of 23.42% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0%	45.7%	9.5%	21.8%	11.7%	14.4%	19.7%	10.2%	10.9%	14%	-
Value Creation Index ⓘ	NA	2.3	-0.3	0.6	-0.2	0.0	0.4	-0.3	-0.2	0	-
Growth Parameters ⓘ
Sales ⓘ	0	216	213	344	257	260	346	315	300	333	301
Sales YoY Gr.	-	NA	-1.3%	61.6%	-25.4%	1.3%	32.8%	-8.8%	-4.8%	11.1%	-
Adj EPS ⓘ	-1.9	12,173.4	16.4	50.7	27.1	41.4	52	37.5	38.8	67	58.8
YoY Gr.	-	NA	-99.9%	209.7%	-46.5%	52.6%	25.7%	-27.8%	3.5%	72.7%	-
BVPS (₹) ⓘ	-8.2	81,838.7	292.4	347.2	374.6	417.9	500.2	542.6	582.9	652.2	709.8
Adj Net Profit ⓘ	-0	12.2	5	15.3	8.2	12.5	15.7	11.4	11.7	20.3	18
Cash Flow from Ops. ⓘ	0	19.7	8	27.3	14	21.6	-14.7	4.6	14.8	28	-
Debt/CF from Ops. ⓘ	0	1.3	3.4	1.7	3.5	2.1	-4.1	18.6	6	2.8	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	5.4%	-1.2%	11.1%
Adj EPS ⓘ	NA	19.8%	8.8%	72.7%
BVPSⓘ	NA	11.7%	9.3%	11.9%
Share Price	-	17.5%	39.5%	8.4%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-67.5	29.8	5.8	15.8	7.5	10.5	11.3	7.2	6.9	10.9	8.6
Op. Profit Mgn % ⓘ	0	13.2	6.2	9.5	9.3	11.5	9.1	8.4	11.5	13.3	13.1
Net Profit Mgn % ⓘ	0	5.6	2.3	4.5	3.2	4.8	4.6	3.6	3.9	6.1	5.9
Debt to Equity ⓘ	-0.4	0.3	0.3	0.5	0.4	0.4	0.4	0.5	0.5	0.4	0.2
Working Cap Days ⓘ	0	85	158	114	159	155	150	182	199	186	112
Cash Conv. Cycle ⓘ	0	13	37	19	23	28	24	46	68	63	32

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0	216	213	344	257	260	346	315	300	333
Operating Expenses ⓘ +	0	187	200	312	233	230	314	289	265	289
Manufacturing Costs	0	42	40	48	38	47	59	50	51	57
Material Costs	0	120	133	230	162	140	208	190	162	169
Employee Cost	0	17	18	21	23	27	33	35	41	46
Other Costs ⓘ	0	8	9	13	10	17	14	13	11	18
Operating Profit ⓘ	-0	28	13	32	24	30	31	26	35	44
Operating Profit Margin (%)	-	13.2%	6.2%	9.4%	9.3%	11.5%	9.1%	8.4%	11.5%	13.3%
Other Income ⓘ +	0	2	3	3	2	1	2	3	4	4
Exceptional Items ⓘ	0	0	0	0	0	0	13	2	0	0
Interest ⓘ	0	6	4	5	5	5	5	5	9	8
Depreciation ⓘ	0	6	6	6	7	7	8	8	10	10
Profit Before Tax ⓘ	-0	18	6	24	13	19	33	18	19	30
Tax ⓘ	0	6	-0	7	4	6	8	5	6	9
Profit After Tax	-0	13	7	17	9	13	25	13	13	21
PAT Margin (%)	-	6.0%	3.1%	4.8%	3.6%	5.1%	7.3%	4.2%	4.4%	6.4%
Adjusted EPS (₹)	-1.9	12,943.2	21.5	55.0	30.3	43.6	84.0	43.7	43.2	70.7
Dividend Payout Ratio (%)	0%	0%	0%	2.70%	0%	3.40%	1.80%	3.40%	3.50%	2.10%

Valuation of Haleos Labs - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	0	82	88	105	113	126	151	164	176	197
Share Capital ⓘ	0	0	3	3	3	3	3	3	3	3
Reserves ⓘ	-0	82	85	102	110	123	148	161	173	194
Debt +	0	20	21	40	45	42	54	76	75	68
Long Term Debt	0	16	15	27	24	22	27	46	28	17
Short Term Debt	0	4	6	13	21	20	27	30	47	50
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	55	44	84	45	62	71	55	50	46
Others Liabilities ⓘ	0	24	24	28	29	46	43	46	51	56
Total Liabilities ⓘ	0	181	178	257	232	276	319	341	352	367
Fixed Assets
Net Fixed Assets ⓘ +	0	73	68	87	94	101	99	140	138	150
Gross Block	0	78	80	104	118	131	128	183	191	213
Accumulated Depreciation	0	6	11	17	24	30	29	43	53	62
CWIP ⓘ	0	0	7	1	2	3	21	1	6	0
Investments ⓘ	0	0	5	26	26	26	23	23	23	23
Inventories	0	44	49	74	61	59	81	80	75	61
Trade Receivables	0	39	27	37	22	30	34	46	49	65
Cash Equivalents	0	0	1	2	2	9	2	1	1	1
Others Assets ⓘ	0	25	20	30	24	49	59	50	59	67
Total Assets ⓘ	0	181	178	257	232	276	319	341	352	367

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	20	8	27	14	22	-15	5	15	28
PBT ⓘ	18	6	24	13	19	20	16	19	30
Adjustment ⓘ	9	8	9	11	10	11	12	15	19
Changes in Working Capital ⓘ	-2	-6	1	-7	-3	-38	-19	-17	-12
Tax Paid ⓘ	-5	-1	-6	-3	-5	-8	-4	-3	-9
Cash Flow From Investing Activity ⓘ +	-8	-7	-43	-13	-6	-7	-28	-14	-14
Capex	-8	-3	-22	-13	-7	-15	-28	-14	-14
Net Investments	-1	-3	-21	-0	1	8	0	-0	-0
Others ⓘ	1	0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	-12	-1	18	-2	-8	15	23	-1	-14
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-8	-1	13	-6	-4	8	24	-9	-13
Interest Paid ⓘ	-3	-2	-2	-3	-3	-2	-2	-5	-4
Dividend Paid ⓘ	0	0	0	-1	0	-0	-0	-0	-0
Others ⓘ	-1	2	7	8	-1	9	1	14	3
Net Cash Flow ⓘ	-0	0	2	-1	8	-8	-1	0	0

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	N/A	31.63	7.64	17.2	8.38	10.99	18.29	8.39	7.68	11.45
ROCE (%)	N/A	45.72	9.48	21.82	11.73	14.36	19.73	10.23	10.94	14.03
Asset Turnover Ratio	0	2.53	1.31	1.73	1.16	1.13	1.27	1.07	0.95	1.02
PAT to CFO Conversion(x)	N/A	1.54	1.14	1.59	1.56	1.69	-0.6	0.38	1.15	1.33
Working Capital Days
Receivable Days	0	62.10	51.20	30.90	37.80	33.10	30.70	41.10	52.70	56.40
Inventory Days	0	69.60	72.20	59.80	87.10	76.20	67.50	83.90	86.10	67
Payable Days	0	84.20	137	101.60	145.50	139.80	116	120.30	117.10	103.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Haleos Labs Ltd FAQs

The current trading price of Haleos Labs on 04-Jun-2026 16:59 is ₹1,400.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Haleos Labs stood at ₹423.3 Cr

The latest P/E ratio of Haleos Labs as of 03-Jun-2026 is 23.81.

The latest P/B ratio of Haleos Labs as of 03-Jun-2026 is 1.97.

The 52-week high of Haleos Labs is ₹1,778.4 and the 52-week low is ₹1,050.1.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Haleos Labs is ₹301 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Haleos Labs Ltd is a average quality company.

The key valuation ratios of Haleos Labs Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Haleos Labs Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Haleos Labs Ltd

No data to display

Haleos Labs Ltd (HALEOSLABS)

Haleos Labs Ltd (HALEOSLABS)

Haleos Labs stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Haleos Labs - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Haleos Labs Ltd FAQs

About Haleos Labs Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Haleos Labs Ltd (HALEOSLABS)

Haleos Labs Ltd (HALEOSLABS)

Haleos Labs stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Haleos Labs - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Haleos Labs Ltd FAQs

What is the share price of Haleos Labs?

What is the market cap of Haleos Labs?

What is the P/E ratio of Haleos Labs?

What is the P/B ratio of Haleos Labs?

What is the 52-week high and low of Haleos Labs?

What is the TTM revenue of Haleos Labs?

Is Haleos Labs Ltd a good quality company?

Is Haleos Labs Ltd undervalued or overvalued?

Is Haleos Labs Ltd a good buy now?

About Haleos Labs Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.